Immune Response Modifiers

DBCAT005712Pharmacologic class

Agents that modify immune responses to exert their therapeutic effect(s). A DrugBank category of 1 drug. 1 of them is approved.

What you can answer from here — as of November 29, 2022

1DrugEach linked to its full drug card
Listed above
2Drug targetsEvery drug–target pair in the class, with bond type
Sign in
81Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Immune Response Modifiers share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account